UZ Leuven
Leuven, 3000, Belgium
NCT Number: NCT04904094
This study will investigate the effect of a 6-week stretching intervention, consisting of a combination of a 2-week casting period and a home-based stretching program of the plantar flexors and hamstrings, on muscle and tendon lengths, range of motion, stiffness, and functional muscle strength. The study will include patients with spastic cerebral palsy aged between 4 and 11 years old with a Gross Motor Function Classification Score (GMFCS) level between I and III.
Looking for future studies?
Notify Me4 year–11 year
All sexes
Interventional
Not applicable
Leuven, 3000, Belgium
This study will investigate the effect of a 6-week stretching intervention on muscle and tendon lengths, range of motion, stiffness, and functional muscle strength. The program consists of a 2-week casting period of the lower legs and a home-based stretching program of the hamstrings, followed by a 4-week stretching program of both the plantar flexors and hamstrings.
The aim is twofold: (1) determine whether a 6-week stretching program for the plantar flexors and knee flexors leads to changes in the morphological muscle and tendon properties of the medial gastrocnemius and semitendinosus, ankle and knee range of motion, muscle strength, gait and gross motor function; and (2) determine the correlation between baseline morphological muscle and tendon properties and the changes in the primary outcome parameters (ankle range of motion and stiffness).
The program will start with a 2-week period of stretching casts for the ankle plantar flexors, combined with a passive stretch program for the hamstrings, followed by a passive and active stretch program for both muscle groups for the remaining 4 weeks. The durations and frequencies for passive and active stretching are based on guidelines published by our own research group and on programs applied by previous research. The program will be set-up as a supervised home-based program on top of the usual care. The morphological muscle and tendon parameters, strength, spasticity, stiffness as well as gross motor function will be assessed before and after the entire 6-week stretching program. At the time of cast removal (after 2 weeks), only the morphological muscle and tendon parameters will be evaluated.
This study includes an intervention and control group which will be group-matched based on diagnosis, GMFCS level and age. The study will include patients with spastic cerebral palsy between 4 and 11 years old and a GMFCS level between I and III. Thirty children with a clinical indication for casting of the lower limb will be included in the intervention group and 30 children without an indication for a specific intervention will be included in the control group. Children in the control group will continue their usual care or normal routine treatment, i.e. physiotherapy and orthotic devices.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lower leg casting in combination with removable upper leg casts for approximately 2 weeks and stretching exercises during casting and 4 weeks after casting.
Time frame: Between baseline, casting removal (2 to 4 weeks after baseline) and 6 to 8 weeks after baseline.
Estimation of the muscle belly and tendon length by 3D freehand ultrasonography. The primary outcome will be the muscle belly/tendon length ratio.
Time frame: Between baseline, casting removal (2 to 4 weeks after baseline) and 6 to 8 weeks after baseline.
Evaluation by an instrumented spasticity assessment
Time frame: Between baseline, casting removal (2 to 4 weeks after baseline) and 6 to 8 weeks after baseline.
Evaluation by goniometry
Time frame: Between baseline, casting removal (2 to 4 weeks after baseline) and 6 to 8 weeks after baseline.
Evaluation of muscle spasticity and stiffness by an instrumented spasticity assessment
Time frame: Between baseline, casting removal (2 to 4 weeks after baseline) and 6 to 8 weeks after baseline.
Evaluation of functional muscle strength by the Adapted Functional Strength measure
Time frame: Between baseline, casting removal (2 to 4 weeks after baseline) and 6 to 8 weeks after baseline.
Estimation of the echointensity by 3D freehand ultrasonography
Time frame: Between baseline, casting removal (2 to 4 weeks after baseline) and 6 to 8 weeks after baseline.
Estimation of muscle volume by 3D freehand ultrasonography
Universitaire Ziekenhuizen KU Leuven
Other
Algorithms for Patient-specific Treatment Planning in Cerebral Palsy Based on the Muscle and Tendon Architecture - Homebased (6-week) Stretching Intervention in Children With Spastic Cerebral Palsy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07310550
Brain Damage, Chronic, Brain Diseases
Los Angeles, California, United States
View Trial DetailsNCT05126693
Brain Damage, Chronic, Brain Diseases
Leuven, Vlaams-Brabant, Belgium
View Trial DetailsNCT06330311
Brain Damage, Chronic, Brain Diseases
Madrid, Spain
View Trial DetailsNCT06481722
Brain Damage, Chronic, Brain Diseases
Giza, Married, Egypt
View Trial Details